Integragen SA (ALINT.PA)

ALINT.PA on Paris Stock Exchange

6:44am EDT
Price Change (% chg)

€0.17 (+3.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ALINT.PA


Integragen SA is a France-based company active in the healthcare sector. It researches and develops biomarkers for use as diagnostic tools in the fields of autism, oncology, diabetes and obesity. It uses an evaluation model with several autism-related genes using a combination of several common polymorphisms (Single-Nucleotide... (more)


Beta: 0.63
Market Cap (Mil.): €27.07
Shares Outstanding (Mil.): 4.97
Dividend: --
Yield (%): --


  ALINT.PA Industry Sector
P/E (TTM): -- 160.04 33.40
EPS (TTM): -0.61 -- --
ROI: -73.24 -3.28 17.27
ROE: -129.50 -7.67 18.02
Search Stocks

BRIEF-IntegraGen jumps 10 pct on collaboration deal with Pfizer

PARIS, April 3 - Integragen SA : * Shares rise 10 percent on collaboration agreement with Pfizer * Agreement with Pfizer to evaluate Integragen's proprietary hepatocellular carcinoma molecular signature

03 Apr 2014

French and Benelux stocks-Factors to watch on April 3

PARIS, April 3 - Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

03 Apr 2014

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: GlobalData
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks